Adicet Bio, Inc. (ACET) stock
ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
$2.93−0.06 (-2.01%)
Close on Nov 12, 2026Market cap $27.43MP/E –Yield –
Adicet Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Adicet Bio's enterprise value was -$5.14M on Nov 11, 2026, against $24.87M a year earlier. Over the last 5 years it ranged from -$148.61M to $515.85M, with a median of $22.32M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.14M | -134.9% |
| 2025 | Dec 31, 2025 | $14.71M | – |
| 2024 | Dec 31, 2024 | -$122.80M | – |
| 2023 | Dec 29, 2023 | -$101.78M | -201.9% |
| 2022 | Dec 30, 2022 | $99.84M | -80.2% |
| 2021 | Dec 31, 2021 | $505.38M | +202.4% |
| 2020 | Dec 31, 2020 | $167.11M | – |
| 2019 | Dec 31, 2019 | -$94.49M | – |
| 2018 | Dec 31, 2018 | -$13.86M | – |
See a number that looks wrong?